{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%2C+Cohort+5&page=2", "query": { "intervention": "Placebo, Cohort 5", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 616, "total_pages": 62, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%2C+Cohort+5&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%2C+Cohort+5&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-04T12:00:30.421Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01471717", "title": "Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "INX-08189 50 mg QD X 5 days", "type": "DRUG" }, { "name": "INX-08189 / Victrelis 800 mg TID X three days", "type": "DRUG" }, { "name": "Victrelis 800 mg TID x 3 days", "type": "DRUG" }, { "name": "Victrelis 800 mg TID with INX-08189 50 mg QD", "type": "DRUG" }, { "name": "Placebo with Victrelis 800 mg", "type": "DRUG" }, { "name": "Cohort 2: Victrelis 800 mg with Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 32, "start_date": "2011-10", "completion_date": "2011-11", "has_results": false, "last_update_posted_date": "2012-06-22", "last_synced_at": "2026-10-04T12:00:30.421Z", "location_count": 1, "location_summary": "Saint Paul, Minnesota", "locations": [ { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01471717" }, { "nct_id": "NCT01147458", "title": "A Study Of The Safety And Efficacy Of PF-04191834 In Patients With Osteoarthritis Of The Knee", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteoarthritis, Knee" ], "interventions": [ { "name": "PF-04191834", "type": "DRUG" }, { "name": "PF-04191834 placebo", "type": "DRUG" }, { "name": "Naproxen placebo", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 190, "start_date": "2010-07", "completion_date": "2011-02", "has_results": true, "last_update_posted_date": "2013-06-06", "last_synced_at": "2026-10-04T12:00:30.421Z", "location_count": 25, "location_summary": "Peoria, Arizona • Phoenix, Arizona • Anaheim, California + 20 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Carmichael", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01147458" }, { "nct_id": "NCT05805826", "title": "To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Clostridoides Difficile Associated Disease" ], "interventions": [ { "name": "C. difficile vaccine (previously studied formulation).", "type": "BIOLOGICAL" }, { "name": "C. difficile vaccine formulation 1.", "type": "BIOLOGICAL" }, { "name": "C. difficile vaccine formulation 2.", "type": "BIOLOGICAL" }, { "name": "C. difficile vaccine formulation 3.", "type": "BIOLOGICAL" }, { "name": "Saline Placebo.", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 936, "start_date": "2023-03-23", "completion_date": "2031-06-19", "has_results": false, "last_update_posted_date": "2026-04-29", "last_synced_at": "2026-10-04T12:00:30.421Z", "location_count": 23, "location_summary": "Phoenix, Arizona • Anaheim, California • Doral, Florida + 17 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Doral", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05805826" }, { "nct_id": "NCT01240915", "title": "A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colitis, Ulcerative" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "MultiStem low dose", "type": "DRUG" }, { "name": "MultiStem high dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 105, "start_date": "2011-02", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2016-02-23", "last_synced_at": "2026-10-04T12:00:30.421Z", "location_count": 37, "location_summary": "San Francisco, California • Lafayette, Colorado • Lakewood, Colorado + 24 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Lafayette", "state": "Colorado" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "Littleton", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01240915" }, { "nct_id": "NCT05864391", "title": "A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Steatohepatitis" ], "interventions": [ { "name": "AZD7503", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 40, "start_date": "2023-03-31", "completion_date": "2024-03-20", "has_results": false, "last_update_posted_date": "2025-07-20", "last_synced_at": "2026-10-04T12:00:30.421Z", "location_count": 9, "location_summary": "Chandler, Arizona • Montclair, California • Hialeah, Florida + 5 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Montclair", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Port Orange", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05864391" }, { "nct_id": "NCT01511900", "title": "A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "CAT 1004", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Catabasis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 44, "start_date": "2011-12", "completion_date": "2012-04", "has_results": false, "last_update_posted_date": "2012-06-08", "last_synced_at": "2026-10-04T12:00:30.421Z", "location_count": 1, "location_summary": "Chula Vista, California", "locations": [ { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01511900" }, { "nct_id": "NCT01273467", "title": "A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Stroke", "Ischemia", "Infarction" ], "interventions": [ { "name": "CNTO 0007 or placebo (Stage A)", "type": "DRUG" }, { "name": "CNTO 0007 or placebo (Stage B)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 13, "start_date": "2010-12", "completion_date": "2013-07", "has_results": false, "last_update_posted_date": "2014-03-18", "last_synced_at": "2026-10-04T12:00:30.421Z", "location_count": 2, "location_summary": "Portland, Oregon • Houston, Texas", "locations": [ { "city": "Portland", "state": "Oregon" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01273467" }, { "nct_id": "NCT03502707", "title": "A Study to Evaluate the Safety and Immunogenicity for Regimen Selection of Ad26.RSV.preF and/or RSV preF Protein Combinations Followed by Expanded Safety Evaluation in Adults Aged 60 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "RSV preF Protein 50 mcg", "type": "BIOLOGICAL" }, { "name": "RSV preF Protein 150 mcg", "type": "BIOLOGICAL" }, { "name": "Ad26.RSV.preF 1*10^11 vp", "type": "BIOLOGICAL" }, { "name": "Mixture of Ad26.RSV.preF 5*10^10 vp Plus RSV preF Protein 50 mcg", "type": "BIOLOGICAL" }, { "name": "Mixture of Ad26.RSV.preF 5*10^10 vp Plus RSV preF Protein 150 mcg", "type": "BIOLOGICAL" }, { "name": "Mixture of Ad26.RSV.preF 1*10^11 vp Plus RSV preF Protein 50 mcg", "type": "BIOLOGICAL" }, { "name": "Mixture of Ad26.RSV.preF 1*10^11 vp Plus RSV preF Protein 150 mcg", "type": "BIOLOGICAL" }, { "name": "Selected Regimen", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Janssen Vaccines & Prevention B.V.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 669, "start_date": "2018-07-06", "completion_date": "2022-05-16", "has_results": true, "last_update_posted_date": "2025-05-25", "last_synced_at": "2026-10-04T12:00:30.421Z", "location_count": 6, "location_summary": "Huntsville, Alabama • San Diego, California • Melbourne, Florida + 3 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03502707" }, { "nct_id": "NCT03276728", "title": "Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Heart Failure", "Healthy Volunteer" ], "interventions": [ { "name": "AMG 986 IV", "type": "DRUG" }, { "name": "AMG 986 PO", "type": "DRUG" }, { "name": "Placebo PO", "type": "DRUG" }, { "name": "Placebo IV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 182, "start_date": "2016-08-12", "completion_date": "2019-04-18", "has_results": true, "last_update_posted_date": "2022-08-08", "last_synced_at": "2026-10-04T12:00:30.421Z", "location_count": 8, "location_summary": "Anaheim, California • Tustin, California • Jacksonville, Florida + 5 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Tustin", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Metairie", "state": "Louisiana" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03276728" }, { "nct_id": "NCT01359319", "title": "Safety and Pharmacokinetics of Sialic Acid Tables in Patients With Hereditary Inclusion Body Myopathy (HIBM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hereditary Inclusion Body Myopathy (HIBM)" ], "interventions": [ { "name": "Sialic Acid Extended Release (SA-ER) Tablets", "type": "DRUG" }, { "name": "Sialic Acid Extended Release (SA-ER) Tables", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ultragenyx Pharmaceutical Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 26, "start_date": "2011-07", "completion_date": "2012-05", "has_results": false, "last_update_posted_date": "2012-05-21", "last_synced_at": "2026-10-04T12:00:30.421Z", "location_count": 2, "location_summary": "Costa Mesa, California • New York, New York", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01359319" } ] }